Compendium of Cancer Genome Aberrations

Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
← Older editNewer edit →
VisualWikitext
No edit summary
Line 2,217: Line 2,217:
|}<br />
|}<br />


==WHO Classification of Tumours of the Central Nervous System Content==
==WHO Central Nervous System Tumours  (5th ed.) Content==
{| class="wikitable"
{| class="wikitable"
|-
|-
Line 2,228: Line 2,228:
!'''Notes'''
!'''Notes'''
|-
|-
|Medulloblastoma, WNT-activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
| Astrocytoma, IDH-mutant||Disease||
|9/20/21
|
|COMPLETE
|
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
|9/22/2022
|2021 template added
|-
|Paediatric-Type Diffuse High-Grade Gliomas
|Overview
|
|
|
|
Line 2,246: Line 2,236:
|
|
|
|
|2021 template added
|-
|-
|Diffuse Midline Glioma, H3 K27-Altered
| Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease||
|Disease
|Laveniya Satgunaseelan (Linda Cooley - previous version)
|
|
|
|
|PENDING
|
|
|Laveniya Satgunaseelan (LS)
|
|
|2021 template added
|-
|Diffuse Hemispheric Glioma, H3 G34-Mutant
|Disease
|Xiaolin (Lynn) Hu
|2/21/2022
|
|
|PENDING
|
|
|LS
|
|
|2021 template added
|-
|-
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype
| Glioblastoma, IDH-wildtype||Disease||
|Disease
|
|
|
|
Line 2,279: Line 2,254:
|
|
|
|
|2021 template added
|-
|-
|Infant-Type Hemispheric Glioma
| Diffuse astrocytoma, MYB- or MYBL1-altered||Disease||
|Disease
|
|
|
|
Line 2,290: Line 2,263:
|
|
|
|
|2021 template added
|-
|-
|Astrocytoma, IDH-Mutant
| Angiocentric glioma||Disease||
|Disease
|
|Riley Lochner (trainee), Shashi Shetty (mentor)
|3/3/2022
|
|
|PENDING
|
|
|LS
|
|
|2021 template added
|-
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted
|Disease
|Riley Lochner (trainee), Shashi Shetty (mentor)
|3/3/2022
|
|
|PENDING
|
|
|LS
|
|
|2021 template added
|-
|-
|Ganglioglioma
| Polymorphous low-grade neuroepithelial tumour of the young||Disease||
|Disease
|
|Leila Moayed-Aloei
|6/30/2022
|
|
|PENDING
|
|
|LS
|
|
|2021 template added
|-
|Pilocytic Astrocytoma
|Disease
|Jeremy Pulvers
|9/13/2022
|
|
|PENDING
|
|
|LS
|
|
|2021 template added
|-
|}<br />
==WHO Classification of Soft Tissue and Bone Tumours Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|NTRK-Rearranged Spindle Cell Neoplasm||Disease||James Solomon, MD, PhD
| Diffuse low-grade glioma, MAPK pathway-altered ||Disease||
|2/20/2022
|
|
|PENDING
|
|
|Alanna Church
|
|
|
|
|-
|}<br />
==WHO Classification of Tumours of Breast Tumours Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|Adenoid Cystic Carcinoma
|Disease||Katherine Geiersbach
|10/12/02022
|
|
|PENDING
|
|
|Hui Chen
|
|
|2021 template added
|-
|-
|Secretory Carcinoma
| Diffuse midline glioma, H3 K27-altered||Disease||
|Disease
|Hui Chen
|10/12/2022
|
|PENDING
|
|
|Katherine Geiersbach
|
|
|2021 template added
|-
|}<br />
==Gene-Specific Pages (IN PROCESS OF AUTOMATING - HOLD ON VOLUNTEERING)==
{| class="wikitable sortable"
!'''Gene'''
!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|BCR
|Brian Davis
|
|
|
|
|Complete
|8/10/18
|
|
|
|
|
|
|-
|-
|ABL1
| Diffuse hemispheric glioma, H3 G34-mutant||Disease||
|Brian Davis
|
|
|
|
|Complete
|4/16/19
|
|
|
|
|
|
|-
|RUNX1
|Brian Davis
|
|
|
|
|Complete
|-
|6/9/19
| Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease||
|
|
|
|
|
|-
|RUNX1T1
|Brian Davis
|
|
|
|
|Complete
|5/23/19
|
|
|
|
|
|
|-
|-
|MYH11
| Infant-type hemispheric glioma||Disease||
|Brian Davis
|
|
|
|
|Complete
|8/6/18
|
|
|
|
|
|
|-
|FLT3
|Kay Weng Choy
|
|
|
|
|Complete
|-
|
| Pilocytic astrocytoma ||Disease||
|
|
|
|
|
|
|-
|NPM1
|Kay Weng Choy
|
|
|
|
|Complete
|
|
|
|
|-
| High-grade astrocytoma with piloid features||Disease||
|
|
|
|
|-
|TP53
|Kay Weng Choy
|
|
|
|
|Complete
|
|
|
|
|
|
|-
| Pleomorphic xanthoastrocytoma||Disease||
|
|
|-
|DNMT3A
|Kay Weng Choy
|
|
|
|
|Complete
|
|
|
|
Line 2,496: Line 2,354:
|
|
|-
|-
|CEBPA
| Subependymal giant cell astrocytoma||Disease||
|Gordana
|
|
|
|
|
|Complete
|
|
|
|
Line 2,506: Line 2,363:
|
|
|-
|-
|IDH1
| Chordoid glioma||Disease||
|Paul De Fazio
|
|
|
|
|
|Complete
|
|
|
|
Line 2,516: Line 2,372:
|
|
|-
|-
|IDH2
| Astroblastoma, MN1-altered||Disease||
|Paul De Fazio
|
|
|
|
|
|Complete
|
|
|
|
Line 2,526: Line 2,381:
|
|
|-
|-
|PML
| Ganglioglioma||Disease||
|Brian Davis
|
|
|
|
|Complete
|12/5/18
|
|
|
|
|
|
|-
|RARA
|Brian Davis
|
|
|
|
|Complete
|-
|8/3/18
| Gangliocytoma||Disease||
|
|
|
|
|
|-
|ETV6
|Brian Davis
|
|
|
|
|Complete
|6/9/19
|
|
|
|
|
|
|-
|-
|KIT
| Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease||
|Brian Davis
|
|
|
|
|Complete
|10/1/18
|
|
|
|
|
|
|-
|CBFB
|Brian Davis
|
|
|
|
|Complete
|-
|8/2/18
| Dysembryoplastic neuroepithelial tumour||Disease||
|
|
|
|
|
|-
|GATA2
|Kay Weng Choy
|
|
|
|
|Complete
|
|
|
|
|
|
|-
| Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease||
|
|
|-
|PTEN
|Beth Pitel
|
|
|
|
|Pending
|
|
|
|
Line 2,596: Line 2,426:
|
|
|-
|-
|MLTT3
| Papillary glioneuronal tumour||Disease||
|
|
|
|
Line 2,604: Line 2,434:
|
|
|
|
|-
| Rosette-forming glioneuronal tumour||Disease||
|
|
|-
|MECOM
|Brian Davis
|
|
|
|
|Pending
|
|
|
|
Line 2,616: Line 2,444:
|
|
|-
|-
|FGFR1(FLT2)
| Myxoid glioneuronal tumour||Disease||
|Brian Davis
|
|
|
|
|
|Pending
|
|
|
|
Line 2,626: Line 2,453:
|
|
|-
|-
|KMT2A
| Diffuse leptomeningeal glioneuronal tumour||Disease||
|
|
|
|
Line 2,634: Line 2,461:
|
|
|
|
|-
| Multinodular and vacuolating neuronal tumour||Disease||
|
|
|-
|DEK
|Wahab A. Khan
|
|
|
|
|Pending
|
|
|
|
Line 2,646: Line 2,471:
|
|
|-
|-
|NUP214
| Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease||
|Wahab A. Khan
|
|
|
|
|
|Pending
|
|
|
|
Line 2,656: Line 2,480:
|
|
|-
|-
|RBM15
| Central neurocytoma||Disease||
|
|
|
|
|
Line 2,666: Line 2,489:
|
|
|-
|-
|MKL1
| Extraventricular neurocytoma||Disease||
|
|
|
|
|
|
|
|
|
|
|-
|DDX41
|Ying Zou
|8/7/20
|
|
|Pending
|
|
|
|
Line 2,686: Line 2,498:
|
|
|-
|-
|ANKRD26
| Cerebellar liponeurocytoma||Disease||
|
|
|
|
|
Line 2,696: Line 2,507:
|
|
|-
|-
|CUX1
| Supratentorial ependymoma||Disease||
|
|
|
|
|
Line 2,706: Line 2,516:
|
|
|-
|-
|TET2
| Supratentorial ependymoma, ZFTA fusion-positive ||Disease||
|
|
|
|
|
Line 2,716: Line 2,525:
|
|
|-
|-
|EZH2
| Supratentorial ependymoma, YAP1 fusion-positive||Disease||
|
|
|
|
|
Line 2,726: Line 2,534:
|
|
|-
|-
|FOXP1
| Posterior fossa ependymoma||Disease||
|
|
|
|
|
Line 2,736: Line 2,543:
|
|
|-
|-
|MYC
| Posterior fossa group A (PFA) ependymoma||Disease||
|
|
|
|
|
Line 2,746: Line 2,552:
|
|
|-
|-
|JAK2
| Posterior fossa group B (PFB) ependymoma||Disease||
|
|
|
|
Line 2,754: Line 2,560:
|
|
|
|
|-
| Spinal ependymoma||Disease||
|
|
|-
|WT1
|DONE
|
|
|
|
|DONE
|
|
|
|
Line 2,766: Line 2,570:
|
|
|-
|-
|CBL
| Spinal ependymoma, MYCN-amplified||Disease||
|
|
|
|
|
Line 2,776: Line 2,579:
|
|
|-
|-
|NF1
| Myxopapillary ependymoma||Disease||
|
|
|
|
|
Line 2,786: Line 2,588:
|
|
|-
|-
|SUZ12
| Subependymoma||Disease||
|
|
|
|
|
Line 2,796: Line 2,597:
|
|
|-
|-
|ERG
| Choroid plexus papilloma||Disease||
|
|
|
|
|
Line 2,806: Line 2,606:
|
|
|-
|-
|EST2
| Atypical choroid plexus papilloma||Disease||
|
|
|
|
|
Line 2,816: Line 2,615:
|
|
|-
|-
|RPS14
| Choroid plexus carcinoma||Disease||
|
|
|
|
|
Line 2,826: Line 2,624:
|
|
|-
|-
|RB1
| Medulloblastoma, WNT-activated||Disease||
|
|
|
|
|
Line 2,836: Line 2,633:
|
|
|-
|-
|MPL
| Medulloblastoma, SHH-activated and TP53-wildtype||Disease||
|
|
|
|
|
Line 2,846: Line 2,642:
|
|
|-
|-
|CHGA
| Medulloblastoma, SHH-activated and TP53-mutant||Disease||
|
|
|
|
|
Line 2,856: Line 2,651:
|
|
|-
|-
|CDH1
| Medulloblastoma, non-WNT/non-SHH||Disease||
|
|
|
|
|
Line 2,866: Line 2,660:
|
|
|-
|-
|SRSF2
| Medulloblastoma, histologically defined||Disease||
|
|
|
|
|
Line 2,876: Line 2,669:
|
|
|-
|-
|DNMT1
| Atypical teratoid/rhabdoid tumour||Disease||
|
|
|
|
|
Line 2,886: Line 2,678:
|
|
|-
|-
|PRDX2
| Cribriform neuroepithelial tumour||Disease||
|
|
|
|
Line 2,894: Line 2,686:
|
|
|
|
|-
| Embryonal tumour with multilayered rosettes||Disease||
|
|
|-
|ASXL1
|DONE
|
|
|
|
|DONE
|
|
|
|
Line 2,906: Line 2,696:
|
|
|-
|-
|MN1
| CNS neuroblastoma, FOXR2-activated||Disease||
|
|
|
|
|
Line 2,916: Line 2,705:
|
|
|-
|-
|SF3A1
| CNS tumour with BCOR internal tandem duplication||Disease||
|
|
|
|
|
Line 2,926: Line 2,714:
|
|
|-
|-
|EP300
| CNS embryonal tumour NEC/NOS||Disease||
|
|
|
|
|
Line 2,936: Line 2,723:
|
|
|-
|-
|JARID2
| Pineocytoma||Disease||
|
|
|
|
|
Line 2,946: Line 2,732:
|
|
|-
|-
|BRCA1
| Pineal parenchymal tumour of intermediate differentiation||Disease||
|
|
|
|
|
Line 2,956: Line 2,741:
|
|
|-
|-
|BRCA2
| Pineoblastoma||Disease||
|
|
|
|
|
Line 2,966: Line 2,750:
|
|
|-
|-
|
| Papillary tumour of the pineal region||Disease||
|
|
|
|
|
Line 2,976: Line 2,759:
|
|
|-
|-
| Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease||
|
|
|
|
Line 2,983: Line 2,767:
|
|
|
|
|-
| Schwannoma||Disease||
|
|
|
|}
==WHO Central Nervous System Tumours  (5th ed.) Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|Astrocytoma, IDH-mutant||Disease||
|
|
|
|
Line 3,008: Line 2,777:
|
|
|-
|-
|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease||
| Neurofibroma||Disease||
|
|
|
|
|
|
|
|-
|Glioblastoma, IDH-wildtype||Disease||
|
|
|
|
Line 3,024: Line 2,786:
|
|
|-
|-
|Diffuse astrocytoma, MYB- or MYBL1-altered||Disease||
| Perineurioma||Disease||
|
|
|
|
|
|
|
|-
|Angiocentric glioma||Disease||
|
|
|
|
Line 3,040: Line 2,795:
|
|
|-
|-
|Polymorphous low-grade neuroepithelial tumour of the young||Disease||
| Hybrid nerve sheath tumours||Disease||
|
|
|
|
|
|
|
|-
|Diffuse low-grade glioma, MAPK pathway-altered||Disease||
|
|
|
|
Line 3,056: Line 2,804:
|
|
|-
|-
|Diffuse midline glioma, H3 K27-altered||Disease||
| Malignant melanotic nerve sheath tumour||Disease||
|
|
|
|
|
|
|
|-
|Diffuse hemispheric glioma, H3 G34-mutant||Disease||
|
|
|
|
Line 3,072: Line 2,813:
|
|
|-
|-
|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease||
| Malignant peripheral nerve sheath tumour||Disease||
|
|
|
|
|
|
|
|-
|Infant-type hemispheric glioma||Disease||
|
|
|
|
Line 3,088: Line 2,822:
|
|
|-
|-
|Pilocytic astrocytoma||Disease||
| Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease||
|
|
|
|
|
|
|
|-
|High-grade astrocytoma with piloid features||Disease||
|
|
|
|
Line 3,104: Line 2,831:
|
|
|-
|-
|Pleomorphic xanthoastrocytoma||Disease||
| Meningioma||Disease||
|
|
|
|
|
|
|
|-
|Subependymal giant cell astrocytoma||Disease||
|
|
|
|
Line 3,120: Line 2,840:
|
|
|-
|-
|Chordoid glioma||Disease||
| Solitary fibrous tumour||Disease||
|
|
|
|
|
|
|
|-
|Astroblastoma, MN1-altered||Disease||
|
|
|
|
Line 3,136: Line 2,849:
|
|
|-
|-
|Ganglioglioma||Disease||
| Haemangiomas and vascular malformations||Disease||
|
|
|
|
|
|
|
|-
|Gangliocytoma||Disease||
|
|
|
|
Line 3,152: Line 2,858:
|
|
|-
|-
|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease||
| Haemangioblastoma||Disease||
|
|
|
|
|
|
|
|-
|Dysembryoplastic neuroepithelial tumour||Disease||
|
|
|
|
Line 3,168: Line 2,867:
|
|
|-
|-
|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease||
| Rhabdomyosarcoma||Disease||
|
|
|
|
|
|
|
|-
|Papillary glioneuronal tumour||Disease||
|
|
|
|
Line 3,184: Line 2,876:
|
|
|-
|-
|Rosette-forming glioneuronal tumour||Disease||
| Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease||
|
|
|
|
|
|
|
|-
|Myxoid glioneuronal tumour||Disease||
|
|
|
|
Line 3,200: Line 2,885:
|
|
|-
|-
|Diffuse leptomeningeal glioneuronal tumour||Disease||
| CIC-rearranged sarcoma||Disease||
|
|
|
|
|
|
|
|-
|Multinodular and vacuolating neuronal tumour||Disease||
|
|
|
|
Line 3,216: Line 2,894:
|
|
|-
|-
|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease||
| Primary intracranial sarcoma, DICER1-mutant||Disease||
|
|
|
|
|
|
|
|-
|Central neurocytoma||Disease||
|
|
|
|
Line 3,232: Line 2,903:
|
|
|-
|-
|Extraventricular neurocytoma||Disease||
| Ewing sarcoma||Disease||
|
|
|
|
|
|
|
|-
|Cerebellar liponeurocytoma||Disease||
|
|
|
|
Line 3,248: Line 2,912:
|
|
|-
|-
|Supratentorial ependymoma||Disease||
| Mesenchymal chondrosarcoma||Disease||
|
|
|
|
|
|
|
|-
|Supratentorial ependymoma, ZFTA fusion-positive||Disease||
|
|
|
|
Line 3,264: Line 2,921:
|
|
|-
|-
|Supratentorial ependymoma, YAP1 fusion-positive||Disease||
| Chondrosarcoma||Disease||
|
|
|
|
|
|
|
|-
|Posterior fossa ependymoma||Disease||
|
|
|
|
Line 3,280: Line 2,930:
|
|
|-
|-
|Posterior fossa group A (PFA) ependymoma||Disease||
| Chordoma||Disease||
|
|
|
|
|
|
|
|-
|Posterior fossa group B (PFB) ependymoma||Disease||
|
|
|
|
Line 3,296: Line 2,939:
|
|
|-
|-
|Spinal ependymoma||Disease||
| Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease||
|
|
|
|
|
|
|
|-
|Spinal ependymoma, MYCN-amplified||Disease||
|
|
|
|
Line 3,312: Line 2,948:
|
|
|-
|-
|Myxopapillary ependymoma||Disease||
| Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease||
|
|
|
|
|
|
|
|-
|Subependymoma||Disease||
|
|
|
|
Line 3,328: Line 2,957:
|
|
|-
|-
|Choroid plexus papilloma||Disease||
| Primary diffuse large B-cell lymphoma of the CNS||Disease||
|
|
|
|
|
|
|
|-
|Atypical choroid plexus papilloma||Disease||
|
|
|
|
Line 3,344: Line 2,966:
|
|
|-
|-
|Choroid plexus carcinoma||Disease||
| Immunodeficiency-associated CNS lymphomas||Disease||
|
|
|
|
|
|
|
|-
|Medulloblastoma, WNT-activated||Disease||
|
|
|
|
Line 3,360: Line 2,975:
|
|
|-
|-
|Medulloblastoma, SHH-activated and TP53-wildtype||Disease||
| Lymphomatoid granulomatosis||Disease||
|
|
|
|
|
|
|
|-
|Medulloblastoma, SHH-activated and TP53-mutant||Disease||
|
|
|
|
Line 3,376: Line 2,984:
|
|
|-
|-
|Medulloblastoma, non-WNT/non-SHH||Disease||
| Intravascular large B-cell lymphoma||Disease||
|
|
|
|
|
|
|
|-
|Medulloblastoma, histologically defined||Disease||
|
|
|
|
Line 3,392: Line 2,993:
|
|
|-
|-
|Atypical teratoid/rhabdoid tumour||Disease||
| MALT lymphoma of the dura||Disease||
|
|
|
|
|
|
|
|-
|Cribriform neuroepithelial tumour||Disease||
|
|
|
|
Line 3,408: Line 3,002:
|
|
|-
|-
|Embryonal tumour with multilayered rosettes||Disease||
| Other low-grade B-cell lymphomas of the CNS||Disease||
|
|
|
|
|
|
|
|-
|CNS neuroblastoma, FOXR2-activated||Disease||
|
|
|
|
Line 3,424: Line 3,011:
|
|
|-
|-
|CNS tumour with BCOR internal tandem duplication||Disease||
| Anaplastic large cell lymphoma (ALK+/ALK−)||Disease||
|
|
|
|
|
|
|
|-
|CNS embryonal tumour NEC/NOS||Disease||
|
|
|
|
Line 3,440: Line 3,020:
|
|
|-
|-
|Pineocytoma||Disease||
| T-cell and NK/T-cell lymphomas||Disease||
|
|
|
|
|
|
|
|-
|Pineal parenchymal tumour of intermediate differentiation||Disease||
|
|
|
|
Line 3,456: Line 3,029:
|
|
|-
|-
|Pineoblastoma||Disease||
| Erdheim-Chester disease||Disease||
|
|
|
|
|
|
|
|-
|Papillary tumour of the pineal region||Disease||
|
|
|
|
Line 3,472: Line 3,038:
|
|
|-
|-
|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease||
| Rosai-Dorfman disease||Disease||
|
|
|
|
|
|
|
|-
|Schwannoma||Disease||
|
|
|
|
Line 3,488: Line 3,047:
|
|
|-
|-
|Neurofibroma||Disease||
| Juvenile xanthogranuloma||Disease||
|
|
|
|
|
|
|
|-
|Perineurioma||Disease||
|
|
|
|
Line 3,504: Line 3,056:
|
|
|-
|-
|Hybrid nerve sheath tumours||Disease||
| Langerhans cell histiocytosis||Disease||
|
|
|
|
|
|
|
|-
|Malignant melanotic nerve sheath tumour||Disease||
|
|
|
|
Line 3,520: Line 3,065:
|
|
|-
|-
|Malignant peripheral nerve sheath tumour||Disease||
| Histiocytic sarcoma||Disease||
|
|
|
|
|
|
|
|-
|Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease||
|
|
|
|
Line 3,536: Line 3,074:
|
|
|-
|-
|Meningioma||Disease||
| Germ cell tumours of the CNS||Disease||
|
|
|
|
|
|
|
|-
|Solitary fibrous tumour||Disease||
|
|
|
|
Line 3,552: Line 3,083:
|
|
|-
|-
|Haemangiomas and vascular malformations||Disease||
| Adamantinomatous craniopharyngioma||Disease||
|
|
|
|
|
|
|
|-
|Haemangioblastoma||Disease||
|
|
|
|
Line 3,568: Line 3,092:
|
|
|-
|-
|Rhabdomyosarcoma||Disease||
| Papillary craniopharyngioma||Disease||
|
|
|
|
|
|
|
|-
|Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease||
|
|
|
|
Line 3,584: Line 3,101:
|
|
|-
|-
|CIC-rearranged sarcoma||Disease||
| Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease||
|
|
|
|
|
|
|
|-
|Primary intracranial sarcoma, DICER1-mutant||Disease||
|
|
|
|
Line 3,600: Line 3,110:
|
|
|-
|-
|Ewing sarcoma||Disease||
| Pituitary adenoma / pituitary neuroendocrine tumour||Disease||
|
|
|
|
|
|
|
|-
|Mesenchymal chondrosarcoma||Disease||
|
|
|
|
Line 3,616: Line 3,119:
|
|
|-
|-
|Chondrosarcoma||Disease||
| Pituitary blastoma||Disease||
|
|
|
|
|
|
|
|-
|Chordoma||Disease||
|
|
|
|
Line 3,632: Line 3,128:
|
|
|-
|-
|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease||
| Metastases to the brain and spinal cord parenchyma||Disease||
|
|
|
|
|
|
|
|-
|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease||
|
|
|
|
Line 3,648: Line 3,137:
|
|
|-
|-
|Primary diffuse large B-cell lymphoma of the CNS||Disease||
| Metastases to the meninges||Disease||
|
|
|
|
|
|
|
|-
|Immunodeficiency-associated CNS lymphomas||Disease||
|
|
|
|
Line 3,664: Line 3,146:
|
|
|-
|-
|Lymphomatoid granulomatosis||Disease||
| Neurofibromatosis type 1||Disease||
|
|
|
|
|
|
|
|-
|Intravascular large B-cell lymphoma||Disease||
|
|
|
|
Line 3,680: Line 3,155:
|
|
|-
|-
|MALT lymphoma of the dura||Disease||
| Neurofibromatosis type 2||Disease||
|
|
|
|
|
|
|
|-
|Other low-grade B-cell lymphomas of the CNS||Disease||
|
|
|
|
Line 3,696: Line 3,164:
|
|
|-
|-
|Anaplastic large cell lymphoma (ALK+/ALK−)||Disease||
| Schwannomatosis||Disease||
|
|
|
|
|
|
|
|-
|T-cell and NK/T-cell lymphomas||Disease||
|
|
|
|
Line 3,712: Line 3,173:
|
|
|-
|-
|Erdheim-Chester disease||Disease||
| Von Hippel-Lindau syndrome||Disease||
|
|
|
|
|
|
|
|-
|Rosai-Dorfman disease||Disease||
|
|
|
|
Line 3,728: Line 3,182:
|
|
|-
|-
|Juvenile xanthogranuloma||Disease||
| Tuberous sclerosis||Disease||
|
|
|
|
|
|
|
|-
|Langerhans cell histiocytosis||Disease||
|
|
|
|
Line 3,744: Line 3,191:
|
|
|-
|-
|Histiocytic sarcoma||Disease||
| Li-Fraumeni syndrome||Disease||
|
|
|
|
|
|
|
|-
|Germ cell tumours of the CNS||Disease||
|
|
|
|
Line 3,760: Line 3,200:
|
|
|-
|-
|Adamantinomatous craniopharyngioma||Disease||
| Cowden syndrome||Disease||
|
|
|
|
|
|
|
|-
|Papillary craniopharyngioma||Disease||
|
|
|
|
Line 3,776: Line 3,209:
|
|
|-
|-
|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease||
| Constitutional mismatch repair deficiency syndrome||Disease||
|
|
|
|
|
|
|
|-
|Pituitary adenoma / pituitary neuroendocrine tumour||Disease||
|
|
|
|
Line 3,792: Line 3,218:
|
|
|-
|-
|Pituitary blastoma||Disease||
| Familial adenomatous polyposis 1||Disease||
|
|
|
|
|
|
|
|-
|Metastases to the brain and spinal cord parenchyma||Disease||
|
|
|
|
Line 3,808: Line 3,227:
|
|
|-
|-
|Metastases to the meninges||Disease||
| Naevoid basal cell carcinoma syndrome||Disease||
|
|
|
|
|
|
|
|-
|Neurofibromatosis type 1||Disease||
|
|
|
|
Line 3,824: Line 3,236:
|
|
|-
|-
|Neurofibromatosis type 2||Disease||
| Rhabdoid tumour predisposition syndrome||Disease||
|
|
|
|
|
|
|
|-
|Schwannomatosis||Disease||
|
|
|
|
Line 3,840: Line 3,245:
|
|
|-
|-
|Von Hippel-Lindau syndrome||Disease||
| Carney complex||Disease||
|
|
|
|
|
|
|
|-
|Tuberous sclerosis||Disease||
|
|
|
|
Line 3,856: Line 3,254:
|
|
|-
|-
|Li-Fraumeni syndrome||Disease||
| DICER1 syndrome||Disease||
|
|
|
|
|
|
|
|-
|Cowden syndrome||Disease||
|
|
|
|
Line 3,872: Line 3,263:
|
|
|-
|-
|Constitutional mismatch repair deficiency syndrome||Disease||
| Familial paraganglioma syndromes||Disease||
|
|
|
|
|
|
|
|-
|Familial adenomatous polyposis 1||Disease||
|
|
|
|
Line 3,888: Line 3,272:
|
|
|-
|-
|Naevoid basal cell carcinoma syndrome||Disease||
| Melanoma-astrocytoma syndrome||Disease||
|
|
|
|
|
|
|
|-
|Rhabdoid tumour predisposition syndrome||Disease||
|
|
|
|
Line 3,904: Line 3,281:
|
|
|-
|-
|Carney complex||Disease||
| Familial retinoblastoma||Disease||
|
|
|
|
|
|
|
|-
|DICER1 syndrome||Disease||
|
|
|
|
Line 3,920: Line 3,290:
|
|
|-
|-
|Familial paraganglioma syndromes||Disease||
| BAP1 tumour predisposition syndrome||Disease||
|
|
|
|
|
|
|
|-
|Melanoma-astrocytoma syndrome||Disease||
|
|
|
|
Line 3,936: Line 3,299:
|
|
|-
|-
|Familial retinoblastoma||Disease||
| Fanconi anaemia||Disease||
|
|
|
|
|
|
|
|-
|BAP1 tumour predisposition syndrome||Disease||
|
|
|
|
Line 3,952: Line 3,308:
|
|
|-
|-
|Fanconi anaemia||Disease||
| ELP1-medulloblastoma syndrome||Disease||
|
|
|
|
|
|
|
|-
|ELP1-medulloblastoma syndrome||Disease||
|
|
|
|
Line 3,968: Line 3,317:
|
|
|-
|-
|}
}
Retrieved from "https://test.ccga.io/index.php/Volunteer_Assignments_and_Opportunities"